Skip to main content
Equibles

Rafferty Asset Management, LLC

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1389426 New York, NY
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$509,227
-$435,382 QoQ
Shares Held
63,574
-46.0% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 208 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $335,902,097 across 164 Biotechnology names. SPRY ranks #118 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 65,798 $32,683,840
2 REGN
Regeneron Pharmaceuticals, Inc.
 38,534 $24,027,490
3 ALNY
Alnylam Pharmaceuticals, Inc.
 55,332 $16,656,591
4 MRNA
Moderna, Inc.
 111,906 $7,836,777
5 INCY
Incyte Corp
 44,663 $5,062,997
6 APGE
Apogee Therapeutics, Inc.
 33,369 $4,429,067
7 TWST
Twist Bioscience Corp
 40,732 $4,190,508
8 ORKA
Oruka Therapeutics, Inc.
 43,110 $4,102,778

All Filings in SPRY

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $509,227 63,574
2026-03-31 $944,609 117,635
2025-12-31 $1,346,320 115,564
2025-09-30 $1,230,220 122,410
2025-06-30 $1,410,762 80,846
2025-03-31 $947,550 75,322
2024-12-31 $1,480,924 140,372
2024-09-30 $1,178,487 81,275
2024-06-30 $726,047 85,317
2024-03-31 $1,140,132 111,559